Vendor review
Shanghai Sigma Audley SSA reviews
Shanghai Sigma Audley SSA reviews from 228 independent lab tests (Retatrutide, Tirzepatide and Tesamorelin): grade A, purity and fill accuracy. Is Shanghai Sigma Audley SSA legit? See what its vials showed.
What the lab tests show
228 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Sep 18, 2026 | Tesamorelin | 10 mg | Fail | View | |
| Sep 18, 2026 | Retatrutide | 30 mg | Fail | View | |
| Sep 14, 2026 | Melanotan II | 10 mg | Fail | View | |
| Aug 3, 2026 | BPC-157 | 98.5 % | 9.35 mg of 10 mg (-7 %) | Pass | View |
| May 6, 2026 | Tirzepatide | 99.9 % | 28 mg of 30 mg (-7 %) | Pass | View |
| May 5, 2026 | Retatrutide | 99.9 % | 4.08 mg of 5 mg (-18 %) | Pass | View |
| May 5, 2026 | GHK-Cu | 99.9 % | 77 mg of 100 mg (-23 %) | Pass | View |
| Mar 29, 2026 | Melanotan II | 99.9 % | 11.8 mg of 10 mg (18 %) | Pass | View |
| Mar 25, 2026 | Tirzepatide | 99.9 % | 12.1 mg of 30 mg (-60 %) | Pass | View |
| Mar 25, 2026 | Tirzepatide | 99.8 % | 10.6 mg of 15 mg (-29 %) | Pass | View |
| Mar 19, 2026 | Tesamorelin | 99.7 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Mar 19, 2026 | Retatrutide | 99.9 % | 16.3 mg of 15 mg (9 %) | Pass | View |
| Mar 18, 2026 | Retatrutide | 99.9 % | 61.6 mg of 60 mg (3 %) | Pass | View |
| Mar 10, 2026 | Retatrutide | 99.9 % | 8.02 mg of 10 mg (-20 %) | Pass | View |
| Mar 10, 2026 | Retatrutide | 99.9 % | 5.01 mg of 5 mg (0 %) | Pass | View |
| Mar 10, 2026 | Retatrutide | 99.9 % | 13 mg of 20 mg (-35 %) | Pass | View |
| Mar 6, 2026 | Melanotan II | 98.5 % | 9.34 mg of 10 mg (-7 %) | Pass | View |
| Mar 4, 2026 | Tirzepatide | 98.95 % | 51.6 mg of 30 mg (72 %) | Pass | View |
| Mar 4, 2026 | Tirzepatide | 99.9 % | 52.2 mg of 60 mg (-13 %) | Pass | View |
| Mar 3, 2026 | Retatrutide | 99.62 % | 30.6 mg of 30 mg (2 %) | Pass | View |
| Mar 3, 2026 | Retatrutide | 99.5 % | 22.4 mg of 20 mg (12 %) | Pass | View |
| Mar 3, 2026 | Semaglutide | 99.85 % | 4.03 mg of 5 mg (-19 %) | Pass | View |
| Feb 20, 2026 | Ipamorelin | 99.62 % | 11.7 mg of 10 mg (17 %) | Pass | View |
| Feb 20, 2026 | GHK-Cu | 99.9 % | 57.8 mg of 50 mg (16 %) | Pass | View |
| Feb 20, 2026 | Sermorelin | 98.99 % | 10.5 mg of 10 mg (5 %) | Pass | View |
| Feb 2, 2026 | Ipamorelin | 99.51 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Jan 26, 2026 | Retatrutide | 99.9 % | 19.7 mg of 20 mg (-2 %) | Pass | View |
| Jan 19, 2026 | BPC-157 | 95.15 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Jan 19, 2026 | GHK-Cu | 99.95 % | 41.2 mg of 50 mg (-18 %) | Pass | View |
| Jan 15, 2026 | Tesamorelin | 96.95 % | 9.18 mg of 10 mg (-8 %) | Pass | View |
| Jan 7, 2026 | Cagrilintide | 99.8 % | 6 mg of 5 mg (20 %) | Pass | View |
| Jan 7, 2026 | Cagrilintide | 99.8 % | 12.6 mg of 10 mg (26 %) | Pass | View |
| Jan 1, 2026 | Ipamorelin | 99.6 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Dec 29, 2025 | Retatrutide | 99.91 % | 16.8 mg of 15 mg (12 %) | Pass | View |
| Dec 13, 2025 | Retatrutide | 99.6 % | 30.8 mg of 30 mg (3 %) | Pass | View |
| Nov 25, 2025 | Retatrutide | 99.95 % | 28.8 mg of 30 mg (-4 %) | Pass | View |
| Nov 23, 2025 | Retatrutide | 99.671 % | 15.37 mg of 10 mg (54 %) | Pass | View |
| Nov 17, 2025 | Retatrutide | 99.4 % | 4.5 mg of 40 mg (-89 %) | Pass | View |
| Nov 14, 2025 | Tirzepatide | 99.8 % | 43.17 mg of 40 mg (8 %) | Pass | View |
| Nov 7, 2025 | GHK-Cu | 99.981 % | 55.14 mg of 50 mg (10 %) | Pass | View |
| Nov 6, 2025 | Retatrutide | 99.95 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Nov 6, 2025 | Sermorelin | 98.88 % | 1.78 mg of 2 mg (-11 %) | Pass | View |
| Nov 6, 2025 | Tirzepatide | 99.49 % | 9.65 mg of 10 mg (-3 %) | Pass | View |
| Nov 6, 2025 | Cagrilintide | 99.19 % | 10.3 mg of 10 mg (3 %) | Pass | View |
| Nov 4, 2025 | Retatrutide | 99.95 % | 50.2 mg of 50 mg (0 %) | Pass | View |
| Nov 4, 2025 | Ipamorelin | 99.9 % | 11.3 mg of 10 mg (13 %) | Pass | View |
| Oct 30, 2025 | Semaglutide | 98.6 % | 22.2 mg of 20 mg (11 %) | Pass | View |
| Oct 30, 2025 | Retatrutide | 99.6 % | 13.1 mg of 13 mg (1 %) | Pass | View |
| Oct 29, 2025 | GHK-Cu | 99.93 % | 40.8 mg of 50 mg (-18 %) | Pass | View |
| Oct 29, 2025 | Tirzepatide | 99.73 % | 12.2 mg of 15 mg (-19 %) | Pass | View |
| Oct 24, 2025 | Retatrutide | 99.7 % | 19.4 mg of 20 mg (-3 %) | Pass | View |
| Oct 24, 2025 | Retatrutide | 99.7 % | 19.4 mg of 20 mg (-3 %) | Pass | View |
| Oct 24, 2025 | Tirzepatide | 99.6 % | 20.1 mg of 20 mg (1 %) | Pass | View |
| Oct 24, 2025 | Retatrutide | 99.5 % | 9.9 mg of 10 mg (-1 %) | Pass | View |
| Oct 23, 2025 | PT-141 | 99.29 % | 9.82 mg of 10 mg (-2 %) | Pass | View |
| Oct 23, 2025 | CJC-1295 | 95.66 % | 5.55 mg of 5 mg (11 %) | Pass | View |
| Oct 23, 2025 | Retatrutide | 99.19 % | 14.5 mg of 15 mg (-3 %) | Pass | View |
| Oct 23, 2025 | Tirzepatide | 99.82 % | 28 mg of 30 mg (-7 %) | Pass | View |
| Oct 23, 2025 | Retatrutide | 99.37 % | 52.6 mg of 50 mg (5 %) | Pass | View |
| Oct 23, 2025 | Retatrutide | 98.9 % | 28.4 mg of 30 mg (-5 %) | Pass | View |
What Shanghai Sigma Audley SSA sells
No current listings on record.
About Shanghai Sigma Audley SSA
DO NOT purchase from sigmaaudley.site: evidence of fraud, verify from a trusted source that you are purchasing from the legitimate vendor, and not from a fake site.